Stacy Gilbert
Primary Care · Murfreesboro, TNNPI 1659131928
Payments from drug & device makers
Across 54 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$193
- EMD Serono, Inc.$178
- AstraZeneca$127
- Biogen$124
- Neurocrine Biosciences, Inc.$70
- Novartis$49
- plus $464 from 21 others
What the payments were for
- Food & beverage$1,18398%
- Education$212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $193 |
| EMD Serono, Inc. | 5 | $178 |
| AstraZeneca | 2 | $127 |
| Biogen | 4 | $124 |
| Neurocrine Biosciences, Inc. | 3 | $70 |
| Novartis | 3 | $49 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| UCB, Inc. | 2 | $36 |
| TG Therapeutics, Inc. | 2 | $34 |
| SK Life Science, Inc. | 1 | $31 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
| Pfizer | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Octapharma USA, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $18 |
| Amgen | 1 | $18 |
| CSL Behring | 1 | $17 |
| Medtronic | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Tandem Diabetes Care, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,204 in reported general payments places this provider in the 65th percentile of 189 primary care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 13 | $252 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 20 | $239 |
| Gabapentin | 17 | $211 |
| Donepezil Hcl | 26 | $210 |
| Propranolol Hcl | 14 | $200 |
| Memantine Hcl | 11 | $184 |
| Levetiracetam | 11 | $176 |
| Primidone | 20 | $129 |
Paid to pharmacies, not to this prescriber.
Other primary care in Murfreesboro
- Reena BhaktaMurfreesboro$12K
- Mary SullivanGermantown$115K
- Len GetzMemphis$25K
- Judith CaldwellNashville$18K
- Mara HutchingsNashville$14K
- Ryan HartmanNashville$11K
- Martha LemonsBrentwood$11K
- Abigail EubankHendersonville$9K
- Corey ClelandSevierville$9K
- Katie JohnsonClarksville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.